Psychopharmacology Lab

Our research focuses on the discovery and preclinical evaluation of novel therapeutics targeting pain and related neurological disorders. In particular, our lab investigates inhibitors of enzymes that regulate lipid signaling pathways involved in pain, inflammation, and anxiety. By combining behavioral pharmacology, molecular approaches, and medicinal chemistry collaborations, we aim to identify new strategies that address both the physical and emotional dimensions of chronic pain.